PF 3845 hydrate
SIGMA/PZ0158 - ≥98% (HPLC)
Synonym: N-
CAS Number: 1196109-52-0
Empirical Formula (Hill Notation): C24H23F3N4O2 · xH2O
Molecular Weight: 456.46 (anhydrous basis)
MDL Number: MFCD21365072
Linear Formula: C24H23F3N4O2 · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C24H23F3N4O2.H2O/c25-2 |
| InChI key | CVQMBUCCSAKASE-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O.FC(F)(F)c1ccc(Oc2cccc(C |
| solubility | DMSO: ≥45 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | PF 3845 hydrate is a potent, irreversible FAAH inhibitor |
| Biochem/physiol Actions: | PF 3845 is a potent, irreversible inhibitor of fatty acid amide hydrolase (FAAH), the principle enzyme involved in the degradation of the endocannabinoid anandamide. The endocannabinoid system is a target for therapeutic pain relief. PF-3845 is a covalent inhibitor that carbamylates FAAH′s serine nucleophile. It high selectivity over other enzymes including FAAH-2. In mouse studies, PF-3845 has been shown to raise brain anandamide levels for up to 24 hr; and in a rat model it produced significant reduction of inflammatory pain.. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |


